7ag0
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[7ag0]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7AG0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7AG0 FirstGlance]. <br> | <table><tr><td colspan='2'>[[7ag0]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7AG0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7AG0 FirstGlance]. <br> | ||
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.104Å</td></tr> |
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7ag0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7ag0 OCA], [https://pdbe.org/7ag0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7ag0 RCSB], [https://www.ebi.ac.uk/pdbsum/7ag0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7ag0 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7ag0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7ag0 OCA], [https://pdbe.org/7ag0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7ag0 RCSB], [https://www.ebi.ac.uk/pdbsum/7ag0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7ag0 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
Line 11: | Line 12: | ||
== Function == | == Function == | ||
[https://www.uniprot.org/uniprot/NOGG_HUMAN NOGG_HUMAN] Essential for cartilage morphogenesis and joint formation. Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite.<ref>PMID:12478285</ref> | [https://www.uniprot.org/uniprot/NOGG_HUMAN NOGG_HUMAN] Essential for cartilage morphogenesis and joint formation. Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite.<ref>PMID:12478285</ref> | ||
- | <div style="background-color:#fffaf0;"> | ||
- | == Publication Abstract from PubMed == | ||
- | Bone morphogenetic proteins (BMPs) are secreted cytokines belonging to the transforming growth factor-beta superfamily. New therapeutic approaches based on BMP activity, particularly for cartilage and bone repair, have sparked considerable interest; however, a lack of understanding of their interaction pathways and the side effects associated with their use as biopharmaceuticals have dampened initial enthusiasm. Here, we used BMP-2 as a model system to gain further insight into both the relationship between structure and function in BMPs and the principles that govern affinity for their cognate antagonist Noggin. We produced BMP-2 and Noggin as inclusion bodies in Escherichia coli and developed simple and efficient protocols for preparing pure and homogeneous (in terms of size distribution) solutions of the native dimeric forms of the two proteins. The identity and integrity of the proteins were confirmed using mass spectrometry. Additionally, several in vitro cell-based assays, including enzymatic measurements, RT-qPCR, and matrix staining, demonstrated their biological activity during cell chondrogenic and hypertrophic differentiation. Furthermore, we characterized the simple 1:1 noncovalent interaction between the two ligands (K(D)ca. 0.4 nM) using bio-layer interferometry and solved the crystal structure of the complex using X-ray diffraction methods. We identified the residues and binding forces involved in the interaction between the two proteins. Finally, results obtained with the BMP-2 N102D mutant suggest that Noggin is remarkably flexible and able to accommodate major structural changes at the BMP-2 level. Altogether, our findings provide insights into BMP-2 activity and reveal the molecular details of its interaction with Noggin. | ||
- | |||
- | Structural analysis of the interaction between human cytokine BMP-2 and the antagonist Noggin reveals molecular details of cell chondrogenesis inhibition.,Robert C, Kerff F, Bouillenne F, Gavage M, Vandevenne M, Filee P, Matagne A J Biol Chem. 2023 Feb;299(2):102892. doi: 10.1016/j.jbc.2023.102892. Epub 2023 , Jan 13. PMID:36642181<ref>PMID:36642181</ref> | ||
- | |||
- | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
- | </div> | ||
- | <div class="pdbe-citations 7ag0" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== |
Revision as of 07:51, 7 February 2024
Complex between the bone morphogenetic protein 2 and its antagonist Noggin
|
Categories: Homo sapiens | Large Structures | Bruck F | Filee P | Herman R | Kerff F | Matagne A | Robert C | Vandevenne M